Фармакотерапия в гериатрической практике. Руководство для врачей

HFSA 2006 Comprehensive Heart Failure Practice Guideline Journal of Cardiac Failure. 2006; 12: e1–e1 22.

Mareev V., Lopatin Yu., Pervez Gh. Possible mechanisms of positive betablocker effects in the treatment of dilated cardiomyopathy // Eur. Heart. J. 1993; 14: 94.

Mac Neil J. H. Review of Sotalol safety in 3257 patients with arrhythmias after 15 June. 1991. Bristol Myers Squibb report, 1993. Data on file.

Mc Murray J. J., Ostergren J., Swedberg K. [et al.]. Effects of candesartan in patients with chronic heart failure and reduced leftventricular systolic functiontaking angiotensin. Convertin genzyme inhibitors: the CHARM. Added trial. // Lancet. 2003; 362: 767 – 771.

Owan T. E., Hodge D. O., Herges R. M. [et al.]. Trends in prevalence and outcome of heart failure with preserved ejection fraction // N. Engl. J. Med. 2006; 355: 251 – 259.

PROGRESS Collaborative Group – Randomized trial of a perindopril – based blood – pressure–lowering regimen among 6105 individuals with previous stroke or transient ischemic attack // Lancet. – 2001; 358: 1033–1041.

Flather M. D., Shibata M. C., Coats A. J. [et al.]. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) // Eur. Heart. J. 2005; 26 (3): 215 – 225.

Fox K. M. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). // Lancet. 2003; 362: 782 – 788.

Fukui K., Suzuki S. Nutritional support in cardiac cachexia // Nippon Rinsho. 2001; 59 Suppl: 438 – 441.

Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricularfunction after acute myocardial infarction // Lancet. 1994; 343: 1115 – 1122.

Philbin E. F., Rocco T. A. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved ventricular systolic function // Am Heart J. 1997; 134: 188 – 195.

Stevenson W. G., Stevenson L. W. Atrial fibrillation in heart failure // N. Engl. J. Med. 1999; 341: 910–1.

Sole M. J., Jeejeebhoy K. N. Conditioned nutritional requirements and the patogenesus and treatment of myocardial failure // Curr Opin Clin Nutr Metab Care. 2000; 3 (6): 417 – 424.

Widimsky J., Kremer H. J., Jerie P. [et al.]. Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active, controlled, double. blind multicentre trial in patients with congestive heart failure // Eur. J. Clin Pharmacol. – 1995; 49: 95 – 102.